Chronic inflammatory activity, elevated levels of advanced glycation end products (AGEs), hyporesponsiveness to erythropoietin, the effects of oxidative stress, and anti-diabetic medicines are also other possible causes of anemia in DM patients [22, 26, 58]. Here, EPO is linked to anemia (phenotype).